Back to results
US 2022/0064645 A1Published application
Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof
AssigneeBeijing Tide Pharmaceutical Co., Ltd.
InventorsYanping ZHAO, Hongjun WANG, Yuanyuan JIANG, Weiting ZHONG, Jianmei PANG, Gong LI, Xiang LI, Yixin HE, Liying ZHOU, Yanan LIU
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of biomedicine, particularly to double-stranded RNA molecules targeting CKIP-1 and uses thereof, particularly to use of the double-stranded RNA molecules for the treatment of inflammatory diseases such as arthritis, particularly rheumatoid arthritis.
Claims15
1-26. (canceled)
A double-stranded RNA (dsRNA) molecule comprising a sense strand shown in SEQ ID NO:
- 71 and an antisense strand shown in SEQ ID NO:
- 72.
Dependencies are inferred from the claim text.